Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...

Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.

An oral small molecule drug may reduce gastrointestinal adverse events for adults using a GLP-1-based obesity drug, according ...

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...

Mangoceuticals (MGRX) stock climbs as the company partners with Eli Lilly (LLY) and Novo Nordisk (NVO) to offer GLP-1 weight ...

The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the ...

A class of synthetic drugs called nitazines have been around since the 1950s — but are quickly gaining a foothold in street drugs.

Placebo is a word with Latin origins meaning “I shall please,” while nocebo means “I shall harm.” More common is the ...

In one of Lagos’ busiest and most chaotic suburbs, Agege’s Isale Oja, dreams are quietly extinguished as dangerous substances ...

Millions of Americans take antidepressants. And like all medication, they come with side effects. Researchers studied 30 different antidepressants... Doctors have long known that antidepressants come ...

Small-molecule technology could soon make easy-to-take GLP-1 pills a reality. Experts expect next-generation diabetes and weight loss drugs to result in greater weight loss and more health benefits.